Cited by 22Hepatitis B Virus StudiesHepatitis C virus researchSchizophrenia research and treatment

Prevalence of hepatitis B virus among chronic schizophrenia patients

Open access
Said, W. M., Saleh, R., Jumaian, N.·2001·Eastern Mediterranean Health Journal

Abstract

We aimed to determine the prevalence of hepatitis B surface antigen (HBsAg) among chronic schizophrenia patients in Jordan. Over a period of 12 months, 192 patients (106 male and 86 female) were tested for hepatitis B virus (HBV) by enzyme immunoassay. An equal number of age- and sex-matched healthy controls was also tested. Of the schizophrenia patients, 14 (10 male and 4 female) were positive for HBsAg while only 5 (4 male and 1 female) of the control subjects tested positive. The difference was not statistically significant but it indicates that chronic schizophrenia patients are a risk group for HBV infection and likely to benefit from preventive measures (health education and immunization against HBV).

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.26719/2001.7.3.526

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

The publisher hasn’t deposited this paper’s reference list.

Research works printed but not linked: 12

  1. [1]1. Cotran RS, Kumar V, Robbins SL eds. Robbins pathologic basis of disease, 4th ed. Philadelphia, WB Saunders Company, 1989.
  2. [6]6. Mosley JW. The epidemiology of viral hepatitis: an overview. American journal of the medical sciences, 1975, 270:253– 70.
  3. [2]2. Kane MA, Clements J, Hu D. Hepatitis B. In: Jamison DT et al., eds. Disease control priorities for developing countries. New York, Oxford University Press for the World Bank, 1993:321–30.
  4. [3]3. The diagnostic and statistical manual of mental disorders, 4th edition. Washington DC. American Psychiatric Association, 1994.
  5. [4]4. Villarejos VM et al. Role of saliva, urine and feces in the transmission of type B hepatitis. New England journal of medicine, 1974, 291:1375–8.
  6. [5]5. MacQuarrie MB, Forghani B, Wolochow DA. Hepatitis B transmitted by a human bite. Journal of the American Medical Association, 1974, 230:723–4.
  7. [7]7. Wright R, McCollum RW, Klatskin G. Australia antigen in acute and chronic liver disease. Lancet, 1969, 2(7612):117–21.
  8. [8]8. Scott RM et al. Experimental transmission of hepatitis B virus by semen and saliva. Journal of infectious disease, 1980, 142:67–71.
  9. [9]9. Reiner NE et al. Asymptomatic rectal mucosal lesions and hepatitis B surface antigen at sites of sexual contact in homoscxual men with persistent hepatitis B virus infection. Annals of internal medicine, 1982, 96:170–3.
  10. [10]10. Darani M, Gerber M. Hepatitis B antigen in vaginal secretions [Letter]. Lancet, 1974, 2(7887):1008.
  11. [11]11. Libikova H et al. Hepatitis B and herpes viral components in the cerebrospinal fluid of chronic schizophrenic and senile demented patients. Acta virologica, 1981, 25(4):182–90.
  12. [12]12. van Damme P, Kane M, Meheus A. Integration of hepatitis B vaccination into Source: WHO Fact sheet No.218, Revised 2001 <!-- image --> national immunisation programmes. Viral Hepatitis Prevention Board. British medical journal, 1997, 314:1033–6.

Cited by

Sorted by citations

Authors
Said, W. M., Saleh, R., & Jumaian, N.
Affiliations
King Hussein Medical Center (JO)
Venue
Eastern Mediterranean Health Journal
Published
2001-09-15
Volume
7
Issue
3
Pages
526-530
ISSN
  • 1020-3397 (ISSN-L)
  • 1687-1634
OpenAlex
W2419651762
Cited by
22
References
0
Citations by year
2024: 1 · 2020: 1 · 2018: 2 · 2017: 2 · 2015: 2 · 2014: 1 · 2012: 2
FWCI
0.00
Type
journal article
Language
en
Open access
Locations
  • Eastern Mediterranean Health Journal (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Epidemiology › Hepatitis B Virus Studies
  • Health Sciences › Medicine › Hepatology › Hepatitis C virus research
  • Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
Keywords
hepatitis B virus, hepatitis B surface antigen, chronic schizophrenia, HBV prevalence, hepatitis B vaccination, health education, Jordan
MeSH terms
Adolescent, Adult, Chronic Disease, Female, Hepatitis B, Hepatitis B Surface Antigens, Humans, Jordan, Male, Middle Aged, Patient Admission, Population Surveillance, Prospective Studies, Risk Factors, Schizophrenia, Time Factors, Case-Control Studies, Seroepidemiologic Studies, Age Distribution, Sex Distribution

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review